Amylin Agonist(Ambrosia Biosciences Inc)

N/A

Report date: 2026/02/24 20:00:16
NME

Base Information

Drug NameAmylin Agonist(Ambrosia Biosciences Inc)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAmylin receptor agonists
TargetsAmylin Receptor
Therapy Area/IndicationsObesityMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmbrosia Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmbrosia Biosciences Inc
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A